•  
  •  
 

Abstract

BACKGROUND:

The widespread use of various drugs in a single procedure and the increasing recognition of

Shuddhi

achieved as per the classics to provide the best result have stimulated interest in the manner in which physicians prescribe drugs. The main sources of this information can be found at the institutional-level like hospitals. These sources reveal a varied prescribing patterns in terms of drugs used for

Snehapana

, drugs used for

Sarvanga abhyanga

, and also in terms of drug selection for

Virechana karma

. It also reveals the pattern in the selection of dose and the duration of the treatment vary greatly among physicians according to their place, practice, disease, and the condition of the patient.

METHODS:

Therefore, a prospective study was conducted from May 2016 to December 2017 at KAHER's Shri BMK Ayurveda Hospital and Research Centre, Belagavi, Karnataka, India. A total of 1138 individuals were screened among which 319 individuals were taken as per the inclusion criteria, in which 300 participants completed the study.

RESULTS:

The outcome was measured on the basis of

SamyakShuddhi Lakshana

(SSL) of

Snehana

and

Virechana karma

. The study revealed that 51.33% of the individuals achieved

avaraShuddhi

, 42.33% achieved

MadhyamaShuddhi

, and 6.34% achieved

PravaraShuddhi

. In mridu koshtha, a total of 160–200 ml of ghrita intake can attain 10–11 vegas, in

Madhyama koshtha

total of 295–1130 ml of ghrita intake can attain 13–18 vegas, and in krurukoshtha total of 90–520 ml of ghrita intake can attain up to 21 vegas over a period of 3 or 5 days. 92.67% times Trivritleha was observed as prescribed drug which also has 30 min onset of Virechanavega with proper

snehaSamyakShuddhi

.

DISCUSSION AND CONCLUSION:

The study is the precursor to improve prescribing patterns and quality of care and thus provides a population based approach to advance clinical pharmacology and improved health outcomes resulting from improved prescribing choices.

Pages

139

Last Page

153

Share

COinS